Skip to main content

Peer Review reports

From: An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial

Original Submission
13 Jul 2019 Submitted Original manuscript
15 Jan 2020 Reviewed Reviewer Report - Kirsty Loudon
14 Feb 2020 Author responded Author comments - Louise F Hill
Resubmission - Version 2
14 Feb 2020 Submitted Manuscript version 2
19 Feb 2020 Editorially accepted
15 Apr 2020 Article published 10.1186/s13063-020-4184-8

You can find further information about peer review here.

Back to article page